Iris S. Kassem

Iris S. Kassem

Auto-generated profile, based on publicly available information

Iris S. Kassem

Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2002 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
CECraig Evinger
Craig Evinger
JBJian-Bin Bao
Jian-Bin Bao
APAlice S. Powers
Alice S. Powers
IKIris S. Kassem
Iris S. Kassem
ESEdward J. Schicatano
Edward J. Schicatano
KPKavita R. Peshori
Kavita R. Peshori

Verified
Journal Article
Open access
PDF file
SLShermaine WY Low
Shermaine WY Low
TCTom Connor
Tom Connor
IKIris S. Kassem
Iris S. Kassem
DCDeborah Mehl Costakos
Deborah Mehl Costakos
Shyam S ChaurasiaShyam S Chaurasia
Shyam S Chaurasia
Retinal diseases such as age-related macular degeneration (AMD), retinopathy of prematurity (ROP), and diabetic retinopathy (DR) are the leading causes of visual impairment worldwide. There is a critical need to understand the structural and cellular components that play a vital role in the pathophysiology of retinal diseases. One potential component is the family of structural proteins called small leucine-rich proteoglycans (SLRPs). SLRPs are crucial in many fundamental biological processes involved in the maintenance of retinal homeostasis. They are present within the extracellular matrix (ECM) of connective and vascular tissues and contribute to tissue organization and modulation of cell growth. They play a vital role in cell–matrix interactions in many upstream signaling pathways involved in fibrillogenesis and angiogenesis. In this comprehensive review, we describe the expression patterns and function of SLRPs in the retina, including Biglycan and Decorin from class I; Fibromodulin, Lumican, and a Proline/arginine-rich end leucine-rich repeat protein (PRELP) from class II; Opticin and Osteoglycin/Mimecan from class III; and Chondroadherin (CHAD), Tsukushi and Nyctalopin from class IV.

1 February 2019 in The American Journal of Pathology
Verified
Journal Article
Closed access
FYFabian P.S. Yu
Fabian P.S. Yu
BSBenjamin S. Sajdak
Benjamin S. Sajdak
JSJakub Sikora
Jakub Sikora
ASAlexander E. Salmon
Alexander E. Salmon
MNMurtaza S. Nagree
Murtaza S. Nagree
JMJeffrey A. Medin
Jeffrey A. Medin

1 January 2006 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
IKIris S. Kassem
Iris S. Kassem
CECraig Evinger
Craig Evinger
Purpose. Too investigate asymmetry in eyelid movements with blinking, the stability of the asymmetry, and its modifiability in normal humans. methods. Differences in the start time and amplitude between the two eyelids were assessed for voluntary blinks and reflex blinks evoked by supraorbital trigeminal nerve stimulation. These variables were also measured before and up to 18 months after 2 hours of unilateral upper lid restraint. results. With voluntary blinks, one eyelid consistently began to close earlier and made a larger eyelid movement than the other eyelid. Stimulation of the supraorbital branch of the trigeminal nerve evoked relatively larger amplitude blinks in one eyelid that correlated with the asymmetries of voluntary blinks. There was a continuum of eyelid asymmetry across all subjects that was stable and independent of other biological asymmetries, such as handedness. Briefly reducing eyelid mobility created a long-lasting change in eyelid asymmetry with blinking. conclusions. Eyelid asymmetry results from differences in the excitability of motoneurons in the left and right facial motor nuclei and does not appear to involve asymmetries in cortical inputs to the brain stem. Because adaptive processes modify the motoneuron excitability that creates eyelid asymmetry, these processes may underlie changes in blinking associated with facial palsy and may play a role in the development of disorders that affect one side of the face, such as hemifacial spasm.

30 December 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EHEileen S. Hwang
Eileen S. Hwang
IKIris S. Kassem
Iris S. Kassem
RARawan Allozi
Rawan Allozi
SKSasha Kravets
Sasha Kravets
KAKhalid Y. Al-Kirwi
Khalid Y. Al-Kirwi
DCDeborah M. Costakos
Deborah M. Costakos
Background: Previous studies found that infants with retinopathy of prematurity (ROP) who were treated for more posterior disease with a greater number of laser spots developed higher myopia. These studies included multiple physicians with variations in laser density. In treatments by a single physician, laser spot count is a better surrogate for area of avascular retina and anterior-posterior location of disease, so that the relationship with myopia can be better assessed. Methods: Our retrospective study included infants treated with laser for ROP by a single surgeon at a single center. Exclusion criteria were irregularities during laser and additional treatment for ROP. We assessed correlation between laser spot count and change in refractive error over time using a linear mixed effects model. Results: We studied 153 eyes from 78 subjects treated with laser for ROP. The average gestational age at birth was 25.3±1.8 weeks, birth weight 737±248 grams, laser spot count 1793±728, and post-treatment follow up 37±29 months. Between corrected ages 0–1 years, the mean spherical equivalent was +0.4±2.3 diopters; between ages 1–2, it was -1.3±3.2D; and ages 2–3 was -0.8±3.1D. Eyes that received more laser spots had significantly greater change in refractive error over time (0.30D more myopia per year per 1000 spots). None of the eyes with hyperopia before 18 months developed myopia during the follow-up period. Conclusions: Greater myopia developed over time in infants with ROP treated by laser to a larger area of avascular retina.

1 October 2012 in Journal of American Association for Pediatric Ophthalmology and Strabismus
Verified
Journal Article
Closed access
IKIris S. Kassem
Iris S. Kassem
SRSteven E. Rubin
Steven E. Rubin
SKSylvia R. Kodsi
Sylvia R. Kodsi